NHC · National Healthcare Corp
$221.19
-7.08 (-3.10%)
At close · Oct 7
Return incl. dividend (before tax)
Market Cap
$3.46B
Shares
15.66M
Volume · Oct 7
100.87K
Avg daily vol (3M)
108.62K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$221.19
Open$225.99
Day$220.40–229.19
52W close$117.43–236.75
Avg vol 30d107K
Short int683K · 4.4% float · 8.4d
Short vol81%
DataJan 2020–Oct 2026
Filing10-Q · Aug 6
Up next
filed Aug 6, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$1.56B
Trailing 12 months
Net income (TTM)
$140.18M
Trailing 12 months
Revenue growth YoY
+8.8%
Year over year
Operating margin
9.3%
Trailing 12 months
P / E (TTM)
25.7
Trailing earnings · reciprocal yield 3.9%
FCF yield
4.1%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
1.1%
Trailing 12 months
Shares change YoY
+1.7%
Year over year · more shares
Price change (1Y)
+92.7%
Trailing year
Short interest
4.4%
Latest settlement · 8.4 days to cover
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Strong
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Low
Market backdrop
VIX 15.1 · calm
Equity put/call 0.63
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+19%
above
Price vs 50-day avg
−1%
below
RSI (14)
46
neutral
MACD trend
Positive
52-week position
87%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−3%
trailing
6-month return
+37%
trailing
YTD return
+61%
this year
Relative strength
+26%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $224 › 200d $186 — 50d above 200d
Institutional flow
Distributing
2 of 252 funds reported for Sep 30 · net -5 sh shares
Insider flow
Distributing
Net -$5.6M over 90 days · 100% sells
Short interest
Falling
4.36% of float · ▼ -8.5% MoM · 8.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
252 holders — near 3-yr high, broad support
Squeeze score
58
elevated · 0–100
Fundamentals
Revenue growth
+16%
Y/Y
EPS growth
+17%
Y/Y
Free cash flow
$148.6M
Valuation
P/E 24.9
in line
Buyback
$25.0M
authorized
Balance sheet
$52.8M
net cash
Quant / Vol
risk profile
Volatility
33%
annualized · 1-yr
Max drawdown
−10%
past year
ATR
2.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+19%
Bullish
Price vs 50-day avg
−1%
Neutral
RSI (14)
46
Neutral
MACD trend
Positive
Bullish
52-week position
87%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $224 › 200d $186 — 50d above 200d
Institutional flow
Distributing
2 of 252 funds reported for Sep 30 · net -5 sh shares
Insider flow
Distributing
Net -$5.6M over 90 days · 100% sells
Short interest
Falling
4.36% of float · ▼ -8.5% MoM · 8.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
252 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $117
Now $221 · 87%
Range high $237
vs 200-day avg +19%
vs 50-day avg -1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted diluted earnings per share non-GAAP | $1.74 | Q2 FY2026 | — |
| assisted living communities | 26 | As of August 1, 2026 | — |
| assisted living units | 1,413 | As of August 1, 2026 | — |
| Average Skilled Nursing Per Diem | $366.88 | Q2 FY2026 | — |
| homecare agencies | 34 | As of August 1, 2026 | — |
| hospice agencies | 33 | As of August 1, 2026 | — |
| independent living units | 775 | As of August 1, 2026 | — |
| Non-GAAP Net income non-GAAP | 27.55M | Q2 FY2026 | — |
GAAP → non-GAAP reconciliationGAAP Net income attributable to National Healthcare Corporation 40.32M
-915K Unrealized gains on marketable equity securities
+1.99M Stock-based compensation expense
+0K Gain on sale of property and equipment
-278K Income tax provision on non-GAAP adjustments
= Non-GAAP Net income 41.11M
|
|||
| skilled nursing beds | 10,323 | As of August 1, 2026 | — |
| skilled nursing facilities | 80 | As of August 1, 2026 | — |
| Total Skilled Nursing Patient Days | 749,723 | Q2 FY2026 | — |
| overall census in owned and leased skilled nursing facilities | 90.1% | the three months ending June 30, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NHC
this stock
National Healthcare Corp
|
$3.46B | +61.3% | +16.1% | 24.9 | 4.4% |
|
HCA
HCA Healthcare, Inc.
|
$97.43B | -5.9% | +7.1% | 15.1 | 2.9% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$27.49B | -14.9% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$20.92B | +30.8% | +0.9% | 10.0 | 2.5% |
|
EHC
Encompass Health Corp
|
$11.93B | +15.4% | +10.5% | 19.7 | 3.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NHC | +0.8% | -2.7% | +37.1% | +0.8% | +61.4% |
| SPY | +1.9% | +1.9% | +10.8% | +1.9% | +14.0% |
| vs SPY | -1.1% | -4.6% | +26.4% | -1.1% | +47.4% |
Capital returns
Latest dividend
$0.67
/ share · ex Sep 30, 2026
Paid (TTM)
$2.62
/ share · 4 payouts
Dividend yield (TTM, derived)
1.18%
Buyback program
· as of Aug 31, 2019
Authorized
$25.00M
Spent (derived)
—
Remaining
—
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.